Nuciferine attenuates lipopolysaccharide-stimulated inflammatory responses by inhibiting p38 MAPK/ATF2 signaling pathways

Citations

WEB OF SCIENCE

35
Citations

SCOPUS

40

초록

Nuciferine, isolated from Nelumbo nucifera (commonly known as lotus) leaves, has been shown to have beneficial effects, including antioxidant, anti-obesity, anti-diabetic, and anti-inflammatory properties. However, little is known about the mechanism of nuciferine action on the inflammatory response. This study aimed to investigate the anti-inflammatory effects of nuciferine and its underlying molecular mechanisms in lipopolysaccharide (LPS)-stimulated murine macrophages. In this study, nuciferine reduced LPS-induced nitric oxide (NO) and prostaglandin E-2 (PGE(2)) production and mRNA expression levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2. Nuciferine also decreased the production of pro-inflammatory cytokines such as interleukin (IL)-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha. Furthermore, nuciferine inhibited the LPS-mediated transcriptional activity of nuclear factor (NF)-kappa B and activator protein (AP)-1, and the nuclear translocation of NF-kappa B p65 and activating transcription factor 2 (ATF2), an AP-1 subunit. Nuciferine also decreased the phosphorylation of I kappa B kinase (IKK), inhibitor of NF-kappa B (I kappa B), NF-kappa B, mitogen-activated protein kinase 3 (MKK3), MKK6, p38 mitogen-activated protein kinase (MAPK), and ATF2. Overall, our findings suggest that nuciferine may exert anti-inflammatory effects in LPS-induced macrophages by inhibiting the NF-kappa B and p38 MAPK/ATF2 signaling pathways.

키워드

Nuciferine; Anti-inflammation; Nuclear factor-kappa B; p38 mitogen-activated protein kinase; Activating transcription factor 2; NF-KAPPA-B; ACUTE KIDNEY INJURY; MAP KINASE; ACTIVATION; CELLS; AP-1; PROTEIN; ROLES; COX-2; ATF2
제목
Nuciferine attenuates lipopolysaccharide-stimulated inflammatory responses by inhibiting p38 MAPK/ATF2 signaling pathways
저자
Kim, Sung-Min; Park, Eun-Jung; Lee, Hae-Jeung
DOI
10.1007/s10787-022-01075-y
발행일
2022-12
유형
Article
저널명
Inflammopharmacology
권
30
호
6
페이지
2373 ~ 2383